CANCER RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175276, encodeId=4dec21e5276a4, content=这个期刊的under review是内审还是外审呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sat Dec 16 14:20:32 CST 2023, time=2023-12-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀？感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家，文章proof回去之后多久能更新啊？网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京)]

2024-04-28 147ce2ffm38(暂无昵称) 来自北京

编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平

8 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175276, encodeId=4dec21e5276a4, content=这个期刊的under review是内审还是外审呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sat Dec 16 14:20:32 CST 2023, time=2023-12-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀？感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家，文章proof回去之后多久能更新啊？网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京)]

2024-05-27 ms2000000610574592 来自江苏省

投稿命中率:25.0
偏重的研究方向：circRNA;铁死亡;黑色素瘤
经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？

33 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175276, encodeId=4dec21e5276a4, content=这个期刊的under review是内审还是外审呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sat Dec 16 14:20:32 CST 2023, time=2023-12-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀？感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家，文章proof回去之后多久能更新啊？网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京)]

2023-06-18 ms2000000311873048 来自湖南省

审稿速度:1.0
偏重的研究方向：肿瘤
经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧

82 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175276, encodeId=4dec21e5276a4, content=这个期刊的under review是内审还是外审呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sat Dec 16 14:20:32 CST 2023, time=2023-12-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀？感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家，文章proof回去之后多久能更新啊？网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京)]

2024-05-24 Anny Dian 来自密歇根

偏重的研究方向：肿瘤基础
经验分享：under editorial consideration 11天了，啥时候送审

2 0

[GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175276, encodeId=4dec21e5276a4, content=这个期刊的under review是内审还是外审呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sat Dec 16 14:20:32 CST 2023, time=2023-12-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀？感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家，文章proof回去之后多久能更新啊？网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京)]

2024-03-11 147c9105m80(暂无昵称) 来自江苏省

under editorial consideration 已经六天了一点动静没有是什么情况呀

29 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175276, encodeId=4dec21e5276a4, content=这个期刊的under review是内审还是外审呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sat Dec 16 14:20:32 CST 2023, time=2023-12-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀？感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家，文章proof回去之后多久能更新啊？网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京)]

2023-09-21 ms1000000959787142 来自天津

各位大佬们，这个杂志under editorial consideration 大概需要多久呀

62 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175276, encodeId=4dec21e5276a4, content=这个期刊的under review是内审还是外审呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sat Dec 16 14:20:32 CST 2023, time=2023-12-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀？感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家，文章proof回去之后多久能更新啊？网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京)]

2023-05-30 ms3000001338909804 来自湖北省

偏重的研究方向：肿瘤基础研究;肿瘤
经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？

81 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175276, encodeId=4dec21e5276a4, content=这个期刊的under review是内审还是外审呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sat Dec 16 14:20:32 CST 2023, time=2023-12-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀？感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家，文章proof回去之后多久能更新啊？网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京)]

2023-12-16 12433741m11(暂无昵称) 来自湖北省

这个期刊的under review是内审还是外审呀？

33 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175276, encodeId=4dec21e5276a4, content=这个期刊的under review是内审还是外审呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sat Dec 16 14:20:32 CST 2023, time=2023-12-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀？感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家，文章proof回去之后多久能更新啊？网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京)]

2022-10-28 嘻嘻哈哈623

请问下大家提交后状态一直是live manuscripts代表什么呀？感觉跟大家的状态不一样呀

65 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2175276, encodeId=4dec21e5276a4, content=这个期刊的under review是内审还是外审呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sat Dec 16 14:20:32 CST 2023, time=2023-12-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096624, encodeId=816c2096624f0, content=请问下大家提交后状态一直是live manuscripts代表什么呀？感觉跟大家的状态不一样呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ee235490897, createdName=嘻嘻哈哈623, createdTime=Fri Oct 28 09:46:16 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147875, encodeId=5c0f214e8751c, content=请问下大家，文章proof回去之后多久能更新啊？网站上一直都还是之前我们提交的pre-proof版本, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3e18315115, createdName=ms9000000602781212, createdTime=Thu Jul 13 17:30:27 CST 2023, time=2023-07-13, status=1, ipAttribution=北京)]

2023-07-13 ms9000000602781212 来自北京

请问下大家，文章proof回去之后多久能更新啊？网站上一直都还是之前我们提交的pre-proof版本

67 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务